PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.51%
Revenue growth under 50% of AVGO's 4.04%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
2.75%
Gross profit growth under 50% of AVGO's 8.86%. Michael Burry would be concerned about a severe competitive disadvantage.
2.63%
EBIT growth below 50% of AVGO's 20.42%. Michael Burry would suspect deeper competitive or cost structure issues.
2.40%
Operating income growth under 50% of AVGO's 20.42%. Michael Burry would be concerned about deeper cost or sales issues.
2.95%
Net income growth under 50% of AVGO's 24.28%. Michael Burry would suspect the firm is falling well behind a key competitor.
3.03%
EPS growth under 50% of AVGO's 26.09%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
3.96%
Diluted EPS growth under 50% of AVGO's 27.27%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.11%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.21%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.20%
Dividend growth under 50% of AVGO's 13.29%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-9.04%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
58.23%
Positive FCF growth while AVGO is negative. John Neff would see a strong competitive edge in net cash generation.
94.62%
10Y revenue/share CAGR under 50% of AVGO's 713.93%. Michael Burry would suspect a lasting competitive disadvantage.
55.90%
5Y revenue/share CAGR at 50-75% of AVGO's 80.31%. Martin Whitman would worry about a lagging mid-term growth trajectory.
38.84%
3Y revenue/share CAGR 1.25-1.5x AVGO's 29.56%. Bruce Berkowitz might see better product or regional expansions than the competitor.
491.32%
10Y OCF/share CAGR under 50% of AVGO's 1391.36%. Michael Burry would worry about a persistent underperformance in cash creation.
191.60%
5Y OCF/share CAGR 1.25-1.5x AVGO's 149.52%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
97.03%
3Y OCF/share CAGR above 1.5x AVGO's 59.14%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
928.53%
Net income/share CAGR at 75-90% of AVGO's 1076.00%. Bill Ackman would press for strategic moves to boost long-term earnings.
138.70%
Below 50% of AVGO's 901.67%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
83.99%
Below 50% of AVGO's 410.83%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
56.79%
Below 50% of AVGO's 570.28%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
42.46%
5Y equity/share CAGR above 1.5x AVGO's 17.00%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
67.39%
Positive short-term equity growth while AVGO is negative. John Neff sees a strong advantage in near-term net worth buildup.
575.06%
Below 50% of AVGO's 3517.17%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
129.88%
Below 50% of AVGO's 296.37%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
49.37%
3Y dividend/share CAGR at 75-90% of AVGO's 60.91%. Bill Ackman wants overhead or revenue enhancements to match competitor's dividend growth.
5.53%
AR growth is negative/stable vs. AVGO's 22.60%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
7.85%
Inventory shrinking or stable vs. AVGO's 17.19%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
2.43%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
5.24%
Positive BV/share change while AVGO is negative. John Neff sees a clear edge over a competitor losing equity.
-5.65%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
0.51%
R&D growth drastically higher vs. AVGO's 0.50%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
4.46%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.